Why KFF Is Launching a Podcast on the Business of Health
Why It Matters
The podcast provides a fast, neutral channel for translating complex market dynamics—especially AI—into actionable insights for policymakers and industry, influencing future health‑care decisions and investments.
Key Takeaways
- •KFF launches podcast to bridge policy and business of healthcare.
- •Focus on AI's impact on delivery, financing, and patient experience.
- •Podcast aims to provide real‑time insights beyond traditional research lag.
- •KFF emphasizes neutrality, data‑driven analysis for policymakers and public.
- •Series will feature leaders from health systems, payers, tech, regulators.
Summary
KFF is debuting a new series called Business of Health, a podcast designed to illuminate the financial, operational, and technological forces shaping American healthcare. Hosted by Chip Kahn and featuring KFF President Drew Altman, the show seeks to close the knowledge gap between policymakers, who set rules, and the industry leaders who implement them. The inaugural focus will be artificial intelligence, exploring how AI reshapes clinical practice, hospital operations, patient experience, and the financing of care. Altman stresses that traditional research lags behind rapid market changes, and a podcast format allows real‑time dialogue with health‑system executives, payer representatives, technology innovators, and regulators. Altman highlights KFF’s long‑standing commitment to neutrality and data‑driven insight, noting that the organization receives “flak” from both political sides—a barometer of credibility. He describes AI as a potential "greatest disruptor" of the healthcare infrastructure, capable of both enhancing and challenging existing delivery models. By delivering timely, expert‑led conversations, the podcast aims to inform legislators, industry stakeholders, and the public, fostering more nuanced policy debates and better‑aligned incentives. Its rapid‑response format could shape investment decisions, regulatory approaches, and ultimately improve patient outcomes in a rapidly evolving sector.
Comments
Want to join the conversation?
Loading comments...